Acute Effects of Continuous and Intermittent Blood Flow Restriction on Sprint Interval Performance and Muscle Oxygen Responses.

ABSTRACT: Wizenberg, AM, Gonzalez-Rojas, D, Rivera, PM, Proppe, CE, Laurel, KP, Stout, JR, Fukuda, DH, Billaut, F, Keller, JL, and Hill, EC. Acute effects of continuous and intermittent blood flow restriction on sprint interval performance and muscle oxygen responses. J Strength Cond Res 37(10): e546-e554, 2023-This investigation aimed to examine the acute effects of continuous and intermittent blood flow restriction (CBFR and IBFR, respectively) during sprint interval training (SIT) on muscle oxygenation, sprint performance, and ratings of perceived exertion (RPE). Fifteen men (22.6 ± 2.4 years; 176 ± 6.3 cm; 80.0 ± 12.6 kg) completed in random order a SIT session with CBFR, IBFR (applied during rest), and no blood flow restriction (NoBFR). Each SIT session consisted of two 30-second all-out sprint tests separated by 2 minutes. Peak power (PP), total work (TW), sprint decrement score (S dec ), RPE, and muscle oxygenation were measured during each sprint. A p value ≤0.05 was considered statistically significant. PP decreased to a greater extent from sprint 1 to sprint 2 during CBFR (25.5 ± 11.9%) and IBFR (23.4 ± 9.3%) compared with NoBFR (13.4 ± 8.6%). TW was reduced similarly (17,835.6 ± 966.2 to 12,687.2 ± 675.2 J) from sprint 1 to sprint 2 for all 3 conditions, but TW was lower (collapsed across time) for CBFR (14,320.7 ± 769.1 J) than IBFR (15,548.0 ± 840.5 J) and NoBFR (15,915.4 ± 771.5 J). There were no differences in S dec (84.3 ± 1.7%, 86.1 ± 1.5%, and 87.2 ± 1.1% for CBFR, IBFR, and NoBFR, respectively) or RPE, which increased from sprint 1 (8.5 ± 0.3) to sprint 2 (9.7 ± 0.1). Collective muscle oxygenation responses increased across time and were similar among conditions, whereas increases in deoxy[heme] and total[heme] were greatest for CBFR. Applying BFR during SIT induced greater decrements in PP, and CBFR resulted in greater decrements in work across repeated sprints. The larger increases in deoxy[heme] and total[heme] for CBFR suggested it may induce greater metabolite accumulation than IBFR and NoBFR when combined with SIT.

Creatine in Health and Disease.

Although creatine has been mostly studied as an ergogenic aid for exercise, training, and sport, several health and potential therapeutic benefits have been reported. This is because creatine plays a critical role in cellular metabolism, particularly during metabolically stressed states, and limitations in the ability to transport and/or store creatine can impair metabolism. Moreover, increasing availability of creatine in tissue may enhance cellular metabolism and thereby lessen the severity of injury and/or disease conditions, particularly when oxygen availability is compromised. This systematic review assesses the peer-reviewed scientific and medical evidence related to creatine's role in promoting general health as we age and how creatine supplementation has been used as a nutritional strategy to help individuals recover from injury and/or manage chronic disease. Additionally, it provides reasonable conclusions about the role of creatine on health and disease based on current scientific evidence. Based on this analysis, it can be concluded that creatine supplementation has several health and therapeutic benefits throughout the lifespan.

Performance and muscle architecture comparisons between starters and nonstarters in National Collegiate Athletic Association Division I women's soccer.

This study compared performance and muscle architecture (MA) changes in starters (S) and nonstarters (NS) during a National Collegiate Athletic Association Division I women's soccer season. Twenty-eight women (19.9 ± 1.1 years; 1.71 ± 0.08 m; 64.7 ± 6.4 kg) were monitored for vertical jump power (VJP), repeated line drills (LDs), 3-dimensional multiple object tracking (3D-MOT), and reaction time (RT) at preseason, midseason, and postseason. Muscle architecture changes using ultrasonography were assessed at preseason and postseason. Comparisons between S (n = 11; 70.0 ± 14.6 min per game) and NS (n = 17; 8.4 ± 8.0 min per game) were performed to make magnitude-based inferences. No differences were seen in VJP during the season in either group. Starters were more likely (81.1%) to decrease LD time than NS, with no differences in fatigue rate. Starters and NS improved 3D-MOT (1.14 ± 0.41 to 1.55 ± 0.43) and RT (0.37 ± 0.05 to 0.34 ± 0.33 seconds), with no differences between groups. Rectus femoris (RF) echo intensity improved (65.57 ± 1.50 to 61.26 ± 1.59) in both groups, with no interactions observed. Cross-sectional area (20.84 ± 3.58 to 21.46 ± 3.66 cm) increased and pennation angle (PANG) (12.58 ± 2.56 to 11.78 ± 2.03°) decreased for both groups in the vastus lateralis (VL). Muscle architecture comparisons between groups revealed S likely decreased VL muscle thickness (MT) and PANG (81.6 and 79.4%, respectively) and possibly decreased RF MT and PANG (65.7 and 59.4%, respectively) when compared with NS. Results indicate that VJP and LD fatigue rate are not changed during a competitive season, but S become faster than NS. Three-dimensional multiple object tracking and RT improve regardless of playing time. Changes in MA indicate that practices alone provide sufficient stimulus for improving muscle quality during the competitive season.

Beta-hydroxy-beta-methyl-butyrate blunts negative age-related changes in body composition, functionality and myofiber dimensions in rats.

PURPOSE: To determine the effects of 16 wk. of beta-hydroxy-beta-methylbutyrate (HMB) administration on age-related changes in functionality and diffusion tensor imaging (DTI) determined myofiber dimensions. METHODS: Twelve young (44 wk.), 6 middle-aged (60 wk.), 10 old (86 wk.), and 5 very old (102 wk.) male Fisher-344 rat's body composition and grip strength were assessed at baseline. Following, 6 young, 6 middle-aged, 5 old and 5 very old rats were sacrificed for baseline myofiber dimensions and gene transcript factor expression in the soleus (SOL) and gastrocnemius (GAS). The remaining 6 young and 5 old rats were given HMB for 16 wk. and then sacrificed. RESULTS: Fat mass increased in the middle-aged control condition (+49%) but not the middle-aged HMB condition. In addition, fat mass declined (-56%) in the old HMB condition but not the old control condition. Normalized strength declined and maintained respectively in the control and HMB conditions from 44 to 60 wk. and increased (+23%) (p < 0.05) from 86 to 102 wk. in only the HMB condition. Declines occurred in myofiber size in all muscles from 44 to 102 wk. in the control condition(-10 to -15%), but not HMB condition. Atrogin-1 mRNA expression in the SOL and GAS muscles was greater in the 102-wk control condition than all other conditions: SOL (+45%) and GAS (+100%). This elevation was blunted by HMB in the 102 wk. old SOL. There was a condition effect in the SOL for myogenin, which significantly increased (+40%) only in the 102-wk. HMB group relative to the 44-wk. group. CONCLUSIONS: HMB may blunt age-related losses of strength and myofiber dimensions, possibly through attenuating the rise in protein breakdown.

Viscoelastic creep in the human skeletal muscle-tendon unit.

The purposes of the present study were to (1) characterize viscoelastic creep in vivo in the human skeletal muscle-tendon unit and (2) to examine the consistency of these responses during a single 30-s stretch. Twelve volunteers (mean +/- SD = 22 +/- 3 years; height = 169 +/- 11 cm; mass = 70 +/- 17 kg) participated in two separate experimental trials. Each trial consisted of a 30-s constant-torque stretch of the plantar flexor muscles. Position (degrees) values were quantified at every 5-s period (0, 5, 10, 15, 20, 25, and 30 s) and the percent change in position was quantified for each 5-s epoch (0-5, 5-10, 10-15, 15-20, 20-25, and 25-30 s) relative to the total increase in the range of motion. In addition, the intraclass correlation coefficient (ICC) and standard errors of the measurement (SEM) were calculated for test-retest reliability. These results indicated that position increased over the entire 30-s stretch (P < 0.05), while the majority of the increases in position (73-85%) occurred during the first 15-20 s. ICC values were >or = 0.994 and SEM values (expressed as percentage of the mean) were

Acute effects of a thermogenic nutritional supplement on cycling time to exhaustion and muscular strength in college-aged men.

BACKGROUND: The purpose of the present study was to examine the acute effects of a thermogenic nutritional supplement containing caffeine, capsaicin, bioperine, and niacin on muscular strength and endurance performance. METHODS: Twenty recreationally-active men (mean +/- SD age = 21.5 +/- 1.4 years; stature = 178.2 +/- 6.3 cm; mass = 76.5 +/- 9.9 kg; VO2 PEAK = 3.05 +/- 0.59 L/min-1) volunteered to participate in this randomized, double-blinded, placebo-controlled, cross-over study. All testing took place over a three-week period, with each of the 3 laboratory visits separated by 7 days (+/- 2 hours). During the initial visit, a graded exercise test was performed on a Lode Corival cycle ergometer (Lode, Groningen, Netherlands) until exhaustion (increase of 25 W every 2 min) to determine the maximum power output (W) at the VO2 PEAK (Parvo Medics TrueOne(R) 2400 Metabolic Measurement System, Sandy, Utah). In addition, one-repetition maximum (1-RM) strength was assessed using the bench press (BP) and leg press (LP) exercises. During visits 2 and 3, the subjects were asked to consume a capsule containing either the active supplement (200 mg caffeine, 33.34 mg capsaicin, 5 mg bioperine, and 20 mg niacin) or the placebo (175 mg of calcium carbonate, 160 mg of microcrystalline cellulose, 5 mg of stearic acid, and 5 mg of magnesium stearate in an identical capsule) 30 min prior to the testing. Testing included a time-to-exhaustion (TTE) ride on a cycle ergometer at 80% of the previously-determined power output at VO2 PEAK followed by 1-RM LP and BP tests. RESULTS: There were no differences (p > 0.05) between the active and placebo trials for BP, LP, or TTE. However, for the BP and LP scores, the baseline values (visit 1) were less than the values recorded during visits 2 and 3 (p

The time course of musculotendinous stiffness responses following different durations of passive stretching.

STUDY DESIGN: Repeated-measures experimental design. OBJECTIVE: To examine the acute effects of different durations of passive stretching on the time course of musculotendinous stiffness (MTS) responses in the plantar flexor muscles. BACKGROUND: Stretching is often implemented prior to exercise or athletic competition, with the intent to reduce the risk of injury via decreases in MTS. METHODS AND MEASURES: Twelve subjects (mean +/- SD age, 24 +/- 3 years; stature, 169 +/- 12 cm; mass, 71 +/- 17 kg) participated in 4 randomly-ordered experimental trials: control with no stretching, 2 minutes (2min), 4 minutes (4min), and 8 minutes (8min) of passive stretching. The passive-stretching trials involved progressive repetitions of 30-second passive stretches, while the control trial involved 15 minutes of resting. MTS assessments were conducted before (prestretching), immediately after (poststretching), and at 10, 20, and 30 minutes poststretching on a Biodex System 3 isokinetic dynamometer. RESULTS: MTS decreased (P<.05) immediately after all stretching conditions (2min, 4min, and 8min). However, MTS for the 2min condition returned to baseline within 10 minutes, whereas MTS after the 4min and 8min passive-stretching conditions returned to baseline within 20 minutes. CONCLUSIONS: Practical durations of passive stretching resulted in significant decreases in MTS; however, these changes return to baseline levels within 10 to 20 minutes.

Do practical durations of stretching alter muscle strength? A dose-response study.

PURPOSE: To examine the time course (immediate, 10, 20, and 30 min) for the acute effects of 2, 4, and 8 min of passive stretching (PS) on isometric peak torque (PT), percent voluntary activation (%VA), EMG amplitude, peak twitch torque (PTT), rate of twitch torque development (RTD), and range of motion (ROM) of the plantarflexors. METHODS: Thirteen volunteers (mean +/- SD age, 22 +/- 3 yr) participated in four randomly ordered experimental trials: control (CON) with no stretching, 2 min (PS2), 4 min (PS4), and 8 min (PS8) of PS. Testing was conducted before (pre), immediately after (post), and at 10, 20, and 30 min poststretching. The PS trials involved varied repetitions of 30-s passive stretches, whereas the CON trial included 15 min of resting. PT, %VA, EMG amplitude, PTT, and RTD were assessed during the twitch interpolation technique, whereas ROM was quantified as the maximum tolerable angle of passive dorsiflexion. RESULTS: PT decreased (P < or = 0.05) immediately after all conditions [CON (4%), PS2 (2%), PS4 (4%), and PS8 (6%)] but returned to baseline at 10, 20, and 30 min poststretching. %VA and EMG amplitude were unaltered (P > 0.05) after all conditions. PTT and RTD decreased (P < or = 0.05) immediately after the PS4 (7%) and the PS8 (6%) conditions only; however, these changes were not sufficient to alter voluntary force production. There were also increases (P < or = 0.05) in ROM after the PS2 (8%), the PS4 (14%), and the PS8 (13%) conditions that returned to baseline after 10 min. CONCLUSION: Practical durations of stretching (2, 4, or 8 min) of the plantarflexors did not decrease isometric PT compared with the CON but caused temporary improvements in the ROM, thereby questioning the overall detrimental influence of PS on performance.